These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26358230)

  • 1. Pharmaceutical compositions for antihypertensive treatments: a patent review.
    Kellici TF; Liapakis G; Tzakos AG; Mavromoustakos T
    Expert Opin Ther Pat; 2015; 25(11):1305-17. PubMed ID: 26358230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case study of patents related to captopril, Squibb's first blockbuster.
    Antunes AM; Guerrante RD; Ávila JP; Lins Mendes FM; Fierro IM
    Expert Opin Ther Pat; 2016 Dec; 26(12):1449-1457. PubMed ID: 27573807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclodextrins: improving the therapeutic response of analgesic drugs: a patent review.
    de Oliveira MG; Guimarães AG; Araújo AA; Quintans JS; Santos MR; Quintans-Júnior LJ
    Expert Opin Ther Pat; 2015; 25(8):897-907. PubMed ID: 25960079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulations of deoxycholic for therapy: a patent review (2011 - 2014).
    Hwang SR; Kim IJ; Park JW
    Expert Opin Ther Pat; 2015; 25(12):1423-40. PubMed ID: 26485465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AT1 antagonists: a patent review (2008 - 2012).
    Mavromoustakos T; Agelis G; Durdagi S
    Expert Opin Ther Pat; 2013 Nov; 23(11):1483-94. PubMed ID: 23968548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of companies and drug classes in the 2007-2011 antihypertensive patent literature.
    Carpino PA; Flynn D
    Pharm Pat Anal; 2012 Mar; 1(1):45-64. PubMed ID: 24236713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of the renal outer medullary potassium channel: a patent review.
    Martelli A; Testai L; Breschi MC; Calderone V
    Expert Opin Ther Pat; 2015; 25(9):1035-51. PubMed ID: 26004420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination perindopril/indapamide for the treatment of hypertension: a review.
    de Leeuw PW
    Expert Opin Pharmacother; 2011 Aug; 12(11):1827-33. PubMed ID: 21651456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of patents on anti-rheumatoid arthritis therapies issued in China.
    Yuan HY; Zhang XL; Zhang XH; Meng L; Wei JF
    Expert Opin Ther Pat; 2015; 25(8):909-30. PubMed ID: 26066366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable synthetic polyesters in the technology of controlled dosage forms of antihypertensive drugs - the overview.
    Bialik M; Kuras M; Sobczak M; Oledzka E
    Expert Opin Drug Deliv; 2019 Sep; 16(9):953-967. PubMed ID: 31369295
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary formulations: what remains to be done?
    Weers JG; Bell J; Chan HK; Cipolla D; Dunbar C; Hickey AJ; Smith IJ
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23 Suppl 2():S5-23. PubMed ID: 21133800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving blood pressure control rates by optimizing combination antihypertensive therapy.
    Epstein BJ
    Expert Opin Pharmacother; 2010 Aug; 11(12):2011-26. PubMed ID: 20590485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Berberine and its derivatives: a patent review (2009 - 2012).
    Singh IP; Mahajan S
    Expert Opin Ther Pat; 2013 Feb; 23(2):215-31. PubMed ID: 23231038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension in 2017: Update in Treatment and Pharmaceutical Innovations.
    Okur ME; Karantas ID; Okur NU; Siafaka PI
    Curr Pharm Des; 2017; 23(44):6795-6814. PubMed ID: 28969533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of formulation on the pharmacokinetics of antiretroviral drugs.
    Bastiaans DE; Cressey TR; Vromans H; Burger DM
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):1019-37. PubMed ID: 24877605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Pharmacology of Alpha-1 Blockers Improving Drug-profile through Novel Formulations.
    Nerurkar RP; Ved JK
    J Assoc Physicians India; 2014 Sep; 62(9 Suppl):9-12. PubMed ID: 26245036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical applications of cyclodextrins: basic science and product development.
    Loftsson T; Brewster ME
    J Pharm Pharmacol; 2010 Nov; 62(11):1607-21. PubMed ID: 21039545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.